Article
Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be denied.
Science immunology - 5 Sept 2025
Anderson Ana C, Rangachari Manu
Abstract excerpt
Loss-of-function mutations in NOD2 may predict positive response to PD-1 blockade monotherapy in cancer.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
